Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Elevation Oncology, Inc. (ELEV)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20
   10-K10-K10-K
Revenues  94.832.217.4
            Revenue growth  194.1%85.6% 
Cost of goods sold  0.00.00.0
Gross profit  94.832.217.4
            Gross margin  100.0%100.0%100.0%
Selling, general and administrative   [+]15.88.51.8
Research and development  78.723.615.5
Other operating expenses  94.532.017.3
EBITDA   [+]-94.2-31.8-17.2
            EBITDA margin  -99.3%-98.7%-98.8%
Depreciation and amortization  0.00.00.0
EBIT   [+]-94.2-31.8-17.2
            EBIT margin  -99.4%-98.8%-98.8%
Non-recurring items  0.30.20.1
Other income (expense), net   [+]1.00.00.0
Pre-tax income  -95.1-32.0-17.3
Income taxes  0.00.00.0
            Tax rate   0.0%0.0%
Net income  -95.1-32.0-17.3
            Net margin  -100.2%-99.4%-99.4%
   
Basic EPS   [+]($4.09)($2.64)($21.80)
Diluted EPS   [+]($4.09)($2.64)($21.80)
   
   
Shares outstanding (basic)   [+]23.312.10.8
Shares outstanding (diluted)   [+]23.312.10.8
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy